Acetylon Pharmaceuticals Presents Encouraging Safety and Clinical Response Data from Ongoing Clinical Trials of ACY ... Acetylon Pharmaceuticals Inc., the leader in development of selective histone deacetylase inhibitors for enhanced therapeutic outcomes, today announced the presentation of clinical data of the Company’s lead candidate, ACY-1215, for the treatment of relapsed or refractory multiple myeloma at the 18th Congress of the European Hematology Association , on June 15th, 2013, in Stockholm, Sweden.
June 17, 2013 - Business Wire via Yahoo! Finance
C David Allis in Newswise (press release) Epigenomics-based research is now a central issue in biology. We will build upon our new knowledge of the human genome and move towards a deeper understanding of how DNA information is dynamically regulated through DNA histone modifications as well... Elias Zerhouni http://www.google.com/url?q=http://en.wikipedia.org/wiki/Elias_Zerhouni&source=dictionary&usg=AFQjCNEqrdmHrt0iOTdZLpvgjWylUhK9Uw National Institutes of Health (press release) http://www.google.com/url?q=http://www.nih.gov/news/health/sep2008/od-29.htm&source=dictionary&usg=AFQjCNENfu7IIYA0iYIE7SEPrvaJ682NTw Sep 29, 2008
47388 64319 histone These findings will impact every walk of biology," said David Allis of Rockefeller University, a leader in studying the regulation and biological roles of histone tags. "Histone modifications are highly dynamic on-off switches that the cell...